Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Shopify shares jumped sharply in pre-market trading after the company reported Q2 2026 results that exceeded analyst forecasts and its own guidance range. Revenue, adjusted EPS, gross merchandise volume and free cash flow all outperformed expectations, while a wave of analyst upgrades ahead of the release amplified investor enthusiasm. A supportive…
FX strategists surveyed in a July 31-August 5 poll expect the U.S. dollar to remain firm over the coming months, with weakness following later in the year. The same respondents produced some of the weakest consensus forecasts for the Japanese yen since this polling began in the early 1990s. While Tokyo's recent unilateral and coordinated interventi…
CVS Health stock climbed 3.2% in pre-market trading after the company reported second-quarter results that beat analyst expectations, raised its 2026 adjusted EPS outlook sharply, and announced a partnership with Eli Lilly to distribute GLP-1 weight-loss therapies through its pharmacy network and app. Improvements in the Aetna medical loss ratio an…
Flutter Entertainment stock plunged in pre-market trade after the company reported adjusted earnings below consensus, narrowed its U.S. revenue forecast, and disclosed a planned CEO transition. The combination of a profit shortfall, weaker guidance and continued investment costs tied to the FanDuel Predicts product weighed on investor sentiment des…
Global Payments shares fell in pre-market trading after the company posted an in-line Q2 adjusted EPS but reduced its full-year adjusted EPS guidance and trimmed its normalized revenue growth outlook, citing travel-volume weakness linked to the Middle East conflict as the primary headwind. The guidance cut, rather than the quarter itself, drove the…
Shares of Shopify climbed sharply in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations across multiple metrics. Revenue, adjusted EPS, gross merchandise volume and free cash flow all posted robust year-over-year gains. Management signaled sustained profitability, while select analysts moved…
Advanced Micro Devices is trading off recent strength but fundamentals and industry signals point to a bigger 2027 data-center CPU cycle that the market is underpricing. With strong free cash flow, low net debt, and growing server wins, AMD looks positioned to convert AI infrastructure demand into durable revenue. This trade targets that re-rating …
CDW shares plunged more than 22% in pre-market trading after the company reported second-quarter 2026 results that beat consensus on both adjusted EPS and revenue but showed a contraction in gross profit margin driven by a shift toward lower-margin hardware and restructuring costs. The firm also disclosed that long-tenured CFO Albert Miralles will …
Bernstein moved Elf Beauty from Market-Perform to Outperform and raised its price target to $113 from $60 after the company's newly introduced hair care line posted stronger-than-expected early sales. The broker also increased earnings forecasts and expanded its valuation multiple, citing the scale of the hair care market and parallels with e.l.f. …
Eli Lilly is trading near record highs after a strong run-up, while Novo Nordisk has underperformed over the past year. The apparent pair trade between the two drugmakers masks an asymmetrical risk/reward: Lilly is priced for near-perfect execution, while Novo offers substantial upside only if it can halt declines and rebuild confidence.
BQP's BQPhy platform, running on the QuantumNOW solver engine, has been integrated into Modovolo's engineering workflow to accelerate design exploration for a new line of 3D-printed drone propellers. The commercial deployment enables orders-of-magnitude greater simulation throughput on existing HPC and GPU resources, allowing Modovolo to evaluate f…
Firefly Neuroscience announced a significant 291% increase in the clinical assessment volumes at Transcranial Magnetic Stimulation (TMS) centers utilizing its FDA-cleared Evoke AI-powered EEG/ERP platform. The company's technology aids clinicians in assessing brain function related to psychiatric and behavioral health conditions, enabling more prec…
Rollins Inc. fell 0.3% in pre-market trading to $37.69 after Argus Research downgraded the pest control company from Buy to Hold. The action compounds a de-rating that began following Rollins' Q2 2026 results in late July, when the company missed on adjusted EPS and revenue, reported weaker adjusted EBITDA and saw operating margin compress amid hig…
LeMaitre Vascular shares slid sharply in pre-market trading after the company reported second-quarter 2026 results that missed consensus on both revenue and earnings and issued weaker near-term and full-year guidance. Despite improvements in operating margin and operating income, the headline shortfalls and guidance cuts prompted investors to repri…
Apple reported a record June quarter with $109.4B revenue and 16% YoY growth, yet the stock fell roughly 10% on guidance and memory-cost concerns. Valuation remains rich (market cap roughly $4.54T; P/E ~36.8), but cash flow is robust ($129.2B FCF). This trade idea sells puts into the weakness to generate income and potentially buy Apple at a price …
Advanced Micro Devices Inc. fell sharply following its quarterly report despite topping earnings and revenue forecasts and issuing guidance above consensus. The steep move highlights the stock's elevated valuation and past gains, creating a delicate risk-reward picture for investors considering a buy-the-dip approach.
Physical AI is shifting from concept to procurement cycle, driving sharp gains across industrial robotics suppliers. Teradyne, Cognex, Keyence and others have seen pronounced rallies as factory automation and humanoid-robot components attract order flows. Valuation gaps, FX exposure for Japan-listed names and single-day share moves create both oppo…
Lithium Argentina has closed $220 million in unsecured debt financing to strengthen its financial position and support the expansion of its Cauchari-Olaroz lithium brine operation. The new facilities, backed by international banks and guaranteed partially by Ganfeng Lithium, will fund Stage 2 expansion projects aimed at increasing lithium carbonate…
Sidus Space (SIDU) is a micro-cap space-as-a-service operator that has moved from pure development toward mission operations and recurring data/services. The company still shows negative cash flow and relies on capital markets, but the Missile Defense Agency award and an expanding order book create a plausible path to recurring revenue. This is a t…
Jazz Pharmaceuticals pairs a string of commercial assets and a positive Phase 3 oncology readout with strong free cash flow and reasonable leverage. That combination supports a re-rating thesis: market is paying a mid-teens multiple today; successful commercialization and additional registry/label wins could push Jazz toward premium biotech/oncolog…
Kura Oncology, a biopharmaceutical company specializing in precision cancer medicines, announced it will release its second quarter 2026 financial results after market close on August 12, 2026, followed by a webcast and conference call. The company is focused on developing small molecule drug candidates targeting cancer signaling pathways and is cu…
CervoMed Inc., a clinical-stage biotech company focused on treatments for age-related brain disorders, announced management's participation in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. They will discuss recent advancements in the clinical development of neflamapimod, their lead drug targeting neuroinflammation and neur…
BriaCell Therapeutics has received FDA clearance for its Investigational New Drug application, allowing the initiation of a Phase 1/2a clinical study of its next-generation personalized immunotherapy, Bria-PROS+, targeting prostate cancer. The therapy incorporates multiple immune activation components designed to enhance clinical efficacy and has p…
Medline Inc. reported an 11.6% increase in second-quarter net sales to $7.7 billion and a 13.4% increase in Adjusted EBITDA to $1.1 billion for Q2 2026, driven by strong organic sales growth and new customer signings. However, net income decreased by 58.3% to $139 million due to a $336 million loss from a fire at the Tracy, California distribution …
Bioventus Inc. announced its second quarter 2026 financial results, reporting a 4% increase in revenue to $153.2 million, driven largely by double-digit growth in Pain Treatments. GAAP earnings improved markedly to $0.47 per diluted share from $0.11 in the prior year, supported by the removal of a $24.6 million valuation allowance on deferred tax a…
